Biosenta Inc.
ZRO
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.70K | 600.00 | 800.00 | -145.40K | 700.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.70K | 600.00 | 800.00 | -145.40K | 700.00 |
| Cost of Revenue | 1.90K | 400.00 | 400.00 | 500.00 | 500.00 |
| Gross Profit | 900.00 | 300.00 | 400.00 | -145.80K | 400.00 |
| SG&A Expenses | 876.00K | 871.70K | 854.00K | 803.90K | 878.40K |
| Depreciation & Amortization | 1.60K | 1.60K | 1.70K | 1.80K | 1.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 912.50K | 906.30K | 880.10K | 826.90K | 909.70K |
| Operating Income | -909.80K | -905.70K | -879.20K | -972.10K | -908.70K |
| Income Before Tax | -1.70M | -1.80M | -1.79M | -1.85M | -1.82M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.70 | -1.80 | -1.79 | -1.85 | -1.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.70M | -1.80M | -1.79M | -1.85M | -1.82M |
| EBIT | -909.80K | -905.70K | -879.20K | -972.10K | -908.70K |
| EBITDA | -908.20K | -904.00K | -877.50K | -970.30K | -906.80K |
| EPS Basic | -0.05 | -0.05 | -0.05 | -0.06 | -0.06 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 |
| EPS Diluted | -0.05 | -0.05 | -0.05 | -0.06 | -0.06 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.03 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 133.31M | 133.43M | 133.06M | 131.06M | 126.07M |
| Average Diluted Shares Outstanding | 133.31M | 133.43M | 133.06M | 131.06M | 126.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |